Dr | Clinical Research Fellow+61 7 3845 3007
Dr Philip Mosley studied at the University of Oxford and obtained a masters degree in physiological sciences and a degree in medicine. He was also captain of the university boxing team and was awarded two full ‘Blues’. He worked as a junior doctor in Manchester before moving to Australia to complete his specialist training in psychiatry.
Dr Mosley is a Fellow of the Royal Australian and New Zealand College of Psychiatry (RANZCP) and has completed an advanced certificate in Consultation-Liaison Psychiatry. As part of his training he also undertook a 2-year neuropsychiatry fellowship at the Royal Brisbane and Women’s Hospital (RBWH) and the Asia-Pacific Centre for Neuromodulation (APCN) at the University of Queensland. Currently, Dr Mosley works as a member of the deep brain stimulation (DBS) team at the APCN and as a clinical research fellow at the QIMR Berghofer Medical Research Institute. He runs a private neuropsychiatry practice and also provides a consultation-liaison psychiatry service to the neurology, medical and surgical wards at St Andrew’s War Memorial Hospital in Brisbane.
Dr Mosley completed his PhD in computational neuroscience and neuroimaging in 2019 under the supervision of Professor Michael Breakspear. Eleven peer-reviewed manuscripts were published from his thesis. He has won prizes from the RANZCP in Old Age Psychiatry and Consultation-Liaison Psychiatry, and he has received research funding from the RBWH Foundation, the RANZCP Young Investigator Grant, Parkinson’s Queensland and Wesley Medical Research. Dr Mosley was awarded an ‘Advance Queensland’ Early Career Fellowship for his Parkinson’s disease research and won the postgraduate medal from the Australian Society for Medical Research for findings arising from this project. In 2020, he won the Early Career Psychiatrist award from the RANZCP, which is presented to the fellow producing the most significant piece of research in the five years since fellowship.
Dr Mosley has been the chief investigator in a study of the neuropsychiatric effects of DBS for Parkinson’s disease and remains the chief investigator in a study of medicinal cannabis for Tourette’s syndrome, a lead investigator in a clinical trial of DBS for obsessive-compulsive disorder and anorexia nervosa, as well as a clinical fellow in a neuroimaging study of Alzheimer’s disease. He is beginning a clinical trial of DBS for severe, treatment-resistant depression.
2020: RANZCP Early Career Psychiatrist Prize
2019: Parkinson’s Queensland Higher Research Degree Travel Award
2018: Postgraduate medal; Australian Society for Medical Research
2018: Best paper; American Society for Stereotactic & Functional Neurosurgery
2017: Best clinical paper; Translational Research Institute Symposium
2014: RANZCP Faculty of Consultation-Liaison Psychiatry Psychiatric Trainee Prize
2013: RANZCP Faculty of Psychiatry of Old Age Basic Psychiatric Trainee Prize
2019: PhD Neuroscience, QIMR Berghofer Research Institute
2015: FRANZCP Psychiatry, Royal Australian & New Zealand College of Psychiatrists
2007: BMBCh Clinical Medicine, University of Oxford, United Kingdom
2004: MA (2:1) Physiological Sciences, University of Oxford, United Kingdom